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Abstract
Importance—Sex is a variable that is poorly controlled for in clinical research.
Objective—Determine if sex bias exists in human surgical clinical research, determine if data are 
reported and analyzed using sex as an independent variable, and identify specialties where the 
greatest and least sex biases exist.
Design—Review and data abstraction from published peer-reviewed manuscripts.
Setting—All original peer-reviewed manuscripts published in 2011 and 2012 in Annals of 
Surgery, American Journal of Surgery, JAMA Surgery, Journal of Surgical Research, and Surgery.
Main Outcome Measures—Study type, location, number and sex of subjects, sex matching, 
and inclusion of sex-based reporting, statistical analysis, and discussion of data.
Results—Of 2,347 articles reviewed, 1,668 included human subjects. After excluding 365 
articles, 1,303 manuscripts remained: 17 (1%) included only males, 41 (3%) included only 
females, 1,020 (78%) included males and females, and 225 (17%) did not document the sex of the 
subjects. While females represent over 50% of the total number of subjects included, considerable 
variability existed with the number of male, female, and unspecified subjects included among the 
journals, between US domestic and international studies, and between single versus multi-center 
studies. For manuscripts included in the study, only 38% reported these data by sex, 33% analyzed 
these data by sex, and 23% included a discussion of sex-based results. Sex matching of the 
subjects included in the research was poor, with only 18% of the studies matching the inclusion of 
both sexes by 80%. Upon analysis of the different surgical specialties, a wide variation in sex-
based inclusion, matching, and data reporting existed, with colorectal surgery having the best 
matching of males and females and cardiac surgery having the worst.
Conclusion—Our data show that sex bias exists in human surgical clinical research. Few studies 
included men and women equally, less than one-third performed data analysis by sex, and there 
was wide variation in inclusion and matching of the sexes among the specialties and the journals 
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reviewed. Because clinical research serves as the foundation for evidence-based medicine, it is 
imperative that this disparity be addressed so that therapies benefit both sexes.
INTRODUCTION
In 1977, the Food and Drug Administration (FDA) barred women of “childbearing 
potential” from participating in clinical research until adequate safety and efficacy 
information could be developed during animal and early clinical studies.2 This act, along 
with perceived challenges with recruiting women, subsequently resulted in the poor 
inclusion of women in clinical trials.3,4 In addition, female subjects have been historically 
regarded as suboptimal research subjects due to the estrous cycle and inherent reproductive 
differences from males, even though data exist to refute this assumption.5,6 Due to the low 
enrollment of women in clinical trials, the National Institutes of Health (NIH) Revitalization 
Act was introduced and signed into law in 1993. This law mandated the inclusion of women 
as subjects in clinical research funded by the NIH. However, recent studies have shown that 
the inclusion of women in clinical trials has only marginally improved.7,8,9
The equal inclusion of men and women in clinical trials is important as exemplified by the 
drug zolpidem (AmbienR), a sleep aid medication. Zolpidem was originally approved by the 
FDA in 1992. In the New Drug Application submitted to the FDA, it was documented that 
the peak drug concentration after administration was 45% higher in females, yet the drug 
was approved for the same dose in both males and females.10 In 2013, it was uncovered that 
some women taking zolpidem were involved in automobile accidents the next morning.11 
Investigation revealed that women metabolized the drug more slowly than men.12 This led to 
a label change approved by the FDA in May 2013, recommending that women take half the 
dose as men.13 It is currently unknown how many other drugs may be metabolized 
differently by sex, or simply work differently in males and females. However, the 
Government Accountability Office (GAO) performed an assessment of adverse events by 
sex and reported that 8 out of 10 drugs removed from the market by the FDA were due to 
adverse events in women.14 It is well known that males and females experience health and 
disease differently, metabolize and respond to some drugs differently, respond to medical 
devices differently, and can have different outcomes following medical interventions.15–24
Surgical research is not immune to this problem. We recently demonstrated that significant 
sex bias exists in surgical biomedical research.25 Based on this study and pressure from the 
advocacy community, the NIH announced that sex must be considered as a variable in all 
NIH funded studies beginning January 2016.26–28 It remains unknown if the same sex bias 
exists in human surgical clinical research. Males and females can have different 
postoperative outcomes, complication rates, and re-admission rates, so it is important to 
know if this problem of sex bias is pervasive in surgery.29–33 Adequately controlling for sex 
as a variable with inclusion, data reporting, and data analysis is important as data derived 
from clinical research serve as the foundation for evidence-based medicine. Thus, the 
objective of this study was to determine if sex bias exists in human surgical clinical research, 
and to identify areas where the greatest and least sex biases exist. We hypothesize that males 
and females are not included in surgical clinical research in equal numbers, and that data are 
not reported or analyzed using sex as an independent variable.
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METHODS
Data Abstraction
Data were collected as previously described by Yoon et al.25 All original manuscripts 
published from January 1, 2011 through December 31, 2012 in the top five ranked American 
non-specialty surgical journals which publish internationally and across specialties were 
reviewed. These journals include Annals of Surgery, American Journal of Surgery, JAMA 
Surgery, Journal of Surgical Research, and Surgery. Only original peer-reviewed research 
articles were included in the study. Articles excluded from data abstraction were review 
articles, letters to the editor, case reports etc. Of the original peer-reviewed research articles, 
articles were further excluded if they included any animal or cell data, the number of 
included subjects was zero or not stated, or the article studied anatomically sex-specific 
disease (e.g. ovarian, testicular, prostate etc.).
Variables abstracted
The following data were abstracted: type of study (i.e. animal, cell, or human), single or 
multi-center study, domestic or international study, whether the manuscript studied a sex 
specific disease by anatomic criteria such as prostate, ovarian, cervical etc., the number and 
sex of each subject studied (if specified), and presence of sex-based data reporting. When 
stratifying for sex-based reporting, articles were assessed for sex-based reporting of data, 
analysis of data by sex, and inclusion of sex-based results in the discussion section. Finally, 
surgical sub-specialty responsible for each study was noted. Specialties in which <10 articles 
were published over the 2-year study period were marked as “other”.
Matching of included subjects by sex
The degree of sex matching for the subjects included within each study was calculated. The 
number of included males and females was considered and the lesser number of subjects 
(male or female) in an individual study was defined as the numerator, and the greater 
number of subjects (male or female) was defined as the denominator for individual studies. 
The percent matching of males and females included as subjects was calculated as the ratio 
of the numerator/denominator multiplied by 100. For example, a 100% match of male and 
females would include 50 males and 50 females as subjects. The equation would equal 50/50 
× 100 = 100%. A 50% matching of male and female subjects would include 50 males and 
only 25 females, with the equation equal to 25/50 × 100 = 50%.
Statistical analysis
Chi-squared tests were employed to examine differences between publications by journal 
which stated or did not state sex, to compare the numbers of males, females, and unspecified 
sex subjects in the studies presented in each journal, between domestic and international 
manuscripts, and between manuscripts published by the different specialties. The differences 
in the distribution of sex matched subjects, sex-based reporting, analysis, and discussion of 
the data by specialty were also assessed using a chi-squared test. Significance was assumed 
for p< 0.05. Analyses were conducted using SAS version 9.4.
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RESULTS
Sex of human subjects is often unstated
In total, 2,347 publications were reviewed among all five surgery journals. Of these, 1,668 
(71%) included human subjects. 365 publications were excluded because they included 
animals or cells, studied a sex-specific disease, or did not report the number of subjects 
included. Of the 1,303 manuscripts reviewed (Table 1), 1,078 (83%) stated the sex of 
subjects included in the study, while 225 (17%) did not state the sex of subjects included 
(Figure 1A). While the pattern of this finding was consistent among all five journals (Figure 
1B), the distribution of these differences were statistically significant. The American Journal 
of Surgery had the most subjects with the sex not stated (26%) while Annals of Surgery had 
the least (8%, p<0.0001). Of the 1,078 manuscripts that stated the sex of the subjects, 17 
(1.6%) were male only studies, 41 (3.8%) were female only studies, and 1,020 (94.6%) 
included males and females (Figure 1C, p<0.0001). These data were similar between US 
domestic and international studies. Of the 771 US domestic publications that stated the sex 
of the subjects, 1.6% were male only, 4.3% were female only, and 94.1% included males and 
females. Of the 532 international publications that stated the sex of the subjects, 1.5% were 
male only, 3.1% were female only, and 95.4% included males and females.
Sex-based reporting, analysis, and discussion of data
Of all studies included, only 38% reported data separately for male and female subjects, 
only 33% performed statistical analysis on data collected by sex, and only 23% of articles 
addressed sex-based results in the discussion section (Figure 2). These data were similar 
between domestic (37%, 32% and 23% respectively) and international studies (40%, 35%, 
and 23% respectively). Between specialties, these data were highly variable. For example, 
endocrine surgery, surgical oncology, colorectal, and thoracic surgery were the highest 
performers in sex-based data reporting, analysis, and discussion of the data (Supplemental 
Table 1, p<0.0001). Breast, bariatric, and cardiac surgery were the lowest performers in sex-
based data reporting, analysis, and discussion of the data (p<0.0001).
Disparity exists with the absolute number of male and female subjects studied
In total, over two years and among the five journals studied, 115,377,213 human subjects 
were included in the published manuscripts. There were 46,111,818 (40%) males, 
58,805,665 (51%) females, and 10,459,730 (9%) unspecified subjects (Figure 3A). After 
excluding manuscripts on which veterans and surgical trainees were the subjects, the sex of 
subjects included were similar: 40% male, 51% female, and 9% unspecified. An analysis of 
manuscripts publishing on cardiac and thyroid disease, which are known to be more 
prominent in women, revealed that the sex of subjects included were 25% male, 59% 
female, and 16% unspecified. The total number of males, females, and unspecified subjects 
between journals was highly variable (Figure 3B, p<0.0001). For example, there were 15%, 
22%, and 63% males, females, and unspecified subjects, respectively, in the American 
Journal of Surgery, but 46%, 52%, and 2% males, females, and unspecified subjects, 
respectively, in Surgery. Similarly, differences were detected between US domestic and 
international studies. In US domestic studies there were 40%, 51%, and 9% male, female, 
and unspecified subjects, respectively, while in international studies there were 48%, 26%, 
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and 26% male, female, and unspecified subjects, respectively (Figure 3C, p<0.0001). In 
single-center studies, there were 46%, 51%, and 3% male, female, and unspecified subjects, 
respectively, while in multi-center studies there were 39%, 51%, 10% male, female, and 
unspecified subjects, respectively, (p < 0.0001).
Disparity in inclusion of subjects by sex exists between surgical specialties
There was inconsistency between surgical subspecialties in the number of male, female, and 
unspecified subjects included in the studies. Articles from trauma/critical care, pediatric, 
thoracic, and cardiac surgery had greater than 50% male subjects (Figure 3D, p<0.0001). 
Surgery-unspecified, endocrine, bariatric, and breast surgery had greater than 50% female 
subjects (Figure 3E, p<0.0001). Transplant, general surgery, and articles regarding surgical 
education and training had greater than 50% of unspecified subjects (Figure 3F, p<0.0001). 
Furthermore, there was a significant difference in overall distribution of male, female, and 
unspecified subjects by specialty (p<0.0001).
Studies do not match included subjects by sex
Among articles which included both males and females, only 2% of articles matched the sex 
of included subjects by 100% (Figure 4A). Only 45% of articles matched included male and 
female subjects by 50%. In comparing specialties, breast and cardiac surgery did not match 
any studies by 100%. Examination of the specialties that matched inclusion of males and 
females by at least 50% revealed that colorectal (p<0.0001), transplant (p<0.0001), pediatric 
surgery (p<0.0001), and surgical oncology (p<0.0001) contained the highest number of 
studies, while breast (p=0.0003), cardiac (p<0.0001), bariatric (p<0.0001) and surgical 
education (p<0.0001) contained the lowest number of studies. There was a significant 
difference in the overall distribution of 50% or greater matching across all specialties (p< 
0.0001) (Figure 4B).
DISCUSSION
In this manuscript we show that significant sex bias exists in human surgical clinical 
research. Most importantly, of the manuscripts reviewed only approximately one-third of 
manuscripts statistically analyzed and reported the data by sex. These data were consistent in 
comparing domestic and international studies, and after excluding surgical education and VA 
studies, the latter of which is predominantly male. Furthermore, the sex of the subjects 
included in the research was not stated in 17% of published peer-reviewed studies. Of those 
manuscripts that stated the sex of the subjects, 95% included both males and females. While 
females represent over 50% of the total number of subjects included in the clinical research 
studies, considerable variability existed with the number of male, female, and unspecified 
subjects included among the journals, between US domestic and international studies, and 
between single versus multi-center studies. The proportions of male, female, and unspecified 
subjects was unchanged with the exclusion of studies conducted at the VA and on surgical 
trainees. There was also wide variability in the number of male, female, and unspecified 
subjects included among the surgical specialties. Finally, sex matching of the subjects 
included in the research is practiced in less than half of the peer-review publications 
reviewed using a very liberal 50% matching criteria. Thus, the results of this study confirm 
Mansukhani et al. Page 5
JAMA Surg. Author manuscript; available in PMC 2017 November 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
our hypothesis that males and females are not included in human surgical clinical research in 
equal numbers, and that data are analyzed and discussed using sex as an independent 
variable in less than one-third of surgical clinical research studies
To our knowledge this is the largest and most comprehensive study to examine sex bias in 
human surgical clinical research. However, there are a few studies in other disciplines that 
examine sex bias in clinical research. The data presented in our study shows an improvement 
compared to the data published by Kwiatkowski et al who showed that in cancer trials more 
men (59.8%) were included than women.34 Meinert et al showed that for clinical trials 
published in United States journals from 1966–1998 the percent of subjects by sex included: 
males and females (55%), males only (12%), females only (11%), and unspecified sex 
(21%).7 Vidaver et al surveyed the medical literature from 1995–2000 and showed that less 
than 20–30% (depending on the year) of the studies analyzed data by sex.35 Similarly, 
Blauwet et al showed that sex specific reporting of data was only 37% in general medical 
journals and 23% in cardiovascular journals, while Geller et al showed that outcomes were 
not reported by sex in 75% of federally funded randomized clinical trials published in 
2009.9,36 Finally, in a study of the orthopedic literature, Hettrich et al showed an increase in 
sex-specific analysis from 19% to 30% from 2000 to 2010.37 These data are remarkable 
given that many diseases have a clear female prevalence.38–44 Of note, our results are 
consistent with the US GAO report to the NIH in October 2015 which revealed that more 
females than males were included in NIH-funded clinical research from 2004–2015. In 
addition, our data on the lack of sex-based reporting and analysis is consistent with the US 
GAO’s report and the Institute of Medicine’s 2010 report on healthcare research. These later 
reports showed that despite the NIH Revitalization act of 1993 and increased female 
enrollment in clinical trials, sex-based reporting and analysis of results remains an area of 
disparity.45,46 Despite good overall inclusion of females in human surgical clinical research, 
we were surprised to find the low rate of matching of subjects with regards to sex. 
Furthermore, we were surprised to find that the sex of the subjects included was still not 
reported in over 17% of peer-reviewed studies published in 2011 and 2012. Finally, the wide 
variation in sex-based data reporting and analysis between surgical specialties was surprising 
in that some specialties included sex-based data reporting and analysis in over 50% of 
published studies, while some specialties included sex-based data reporting and analysis in 
less than 10% of published studies. Together, our data imply that sex disparity exists in 
human surgical clinical research in many ways despite the government mandate of female 
inclusion in NIH-funded clinical trials.
Implications of these findings are numerous. First, drugs, therapies, and devices may be 
developed that are effective for only one sex.47 Second, for therapies and drugs that are 
reported to have an overall low efficacy in men and women when the data is aggregated, the 
therapy or drug may be abandoned; however, that therapy or drug may have greater efficacy 
in one sex versus the other. This would only be known if sex-based analysis and reporting of 
the data was performed. For example, the Human Papilloma Virus vaccine is much more 
effective in women versus men.48,49 But, in aggregate, the efficacy is low. If sex-based 
reporting of the data was not conducted, this therapy that is effective at preventing cervical 
papillomas in women may not have been developed. Third, therapies may be developed that 
have undesirable side effects in the opposite sex. For example, the odds of an adverse drug 
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reaction in women is 50% greater than in men, women are more likely to be hospitalized due 
to an adverse drug reaction, and 80% of the drugs removed from the market by the FDA 
were due to undesirable side effects in women.14,50,51 Thus, while it is important to 
aggregate data of both males and females, performing independent data analysis and 
reporting for both males and females can yield discoveries leading to valuable contributions 
to the health and wellbeing of males or females independently.
We acknowledge and understand that there are criticisms to including both sexes and 
accounting for sex differences in clinical research. 52–55 However, our recommendations are 
for an FDA mandate that requires drugs, devices, and new therapies to be tested equally in 
male and female subjects prior to market approval. Drugs which have been recalled due to 
adverse effects in one sex should be tested independently in both sexes as these drugs may 
be candidates for re-release with different dosing parameters for each sex. Research funding 
agencies such as the NIH, National Science Foundation, Department of Defense, the 
Veterans Affairs Administration, etc. should mandate researchers to match inclusion of 
males and females in clinical research, and report results independently for males and 
female subjects so that sex may be examined as in independent variable. Journal editors 
should require authors to include the sex of all subjects studied in published literature and 
require sex-based reporting, analysis, and discussion of data. In support of these views, the 
IOM recently published guidelines for sex-specific reporting of research.56 Finally, 
government monitoring of sex-based inclusion of subjects, sex as an independent variable, 
and sex-based data reporting should be required, especially for research conducted using 
government funds. Such practices have been adopted by other countries and the U.S. should 
follow suit.57
Limitations exist within this study. Our study design was intended to capture a representative 
sampling of surgical clinical research, not a complete analysis of all surgical clinical 
research. The scope of this study was limited to manuscripts published in only five surgery 
journals over a two year period. These journals publish mainly on general surgery topics so 
there was a paucity of manuscripts from certain surgical sub-specialties such as neurological 
surgery, urology, orthopedic surgery, and plastic surgery. There was no inclusion or 
specification regarding the difference between sex and gender, and this study focused solely 
on the differences between phenotypic male and female sex.58 Furthermore, these are 
observational data intended to highlight differences in inclusion, reporting, and analysis 
between sexes, and are not corrected for specific disease prevalence. Data capture for 
funding source was not consistent among the manuscripts; thus, we were not able to 
consistently and reliably discern if the research was funded and if it was funded by the NIH 
versus industry. Lastly, within the manuscripts analyzed for this study there were too few 
randomized controlled trials to develop meaningful conclusions; thus, we are conducting a 
separate study analyzing sex bias in all clinical trials registered with clinicaltrials.gov over a 
defined time period.
In conclusion, this study shows that sex bias exists in human surgical clinical research. Few 
publications included men and women equally, less than one-third performed data analysis 
by sex, and there was wide variation in inclusion and matching of the sexes between the 
specialties and the journals reviewed. Because clinical research serves as the foundation for 
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evidence-based medicine, it is imperative that this disparity be addressed because therapies 
and practice derived from such studies may be specific to only one sex.
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Figure 1. Sex of Subjects Included
Number and percent of manuscripts which state the sex of the human subjects included in 
(A) all manuscripts and (B) by journal. The distribution of rates of sex stated/not stated was 
different between journals (p<0.0001). (C) Number and percent of manuscripts that include 
male only, female only, and male and female subjects.
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Figure 2. Sex-Based Data Reporting
(A) Percent of manuscripts that reported the data by sex. (B) Percent of manuscripts that 
statistically analyzed the data by sex. (C) Percent of manuscripts that included a discussion 
of the results by sex.
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Figure 3. Number of Male and Female Subjects Included
Absolute number of male, female, and unspecified subjects included in (A) all manuscripts, 
(B) by journal, (C) in US domestic and international studies. Distribution of included males, 
females, and unspecified subjects between journals and between domestic and international 
studies was different (p<0.0001). (D) Number of male subjects included by specialty. (E) 
Number of female subjects included by specialty. (F) Number of unspecified subjects 
included by specialty. Distribution of included males, females, and unspecified subjects was 
different by specialty (p<0.0001).
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Figure 4. Sex Matching of Subjects
(A) Degree of sex matching in all manuscripts and (B) by specialty. There is a statistically 
significant difference in distribution of 50% or greater matching across all specialties 
(p<0.0001).
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Table 1
Characteristics of all articles included across journals, centers, and specialties.
# Manuscripts (%)
Total 1303
Journal
American Journal of Surgery 392 (30.1%)
Journal of Surgical Research 116 (8.9%)
JAMA* Surgery 256 (19.6%)
Surgery 266 (20.4%)
Annals of Surgery 273 (21.0%)
Single & Multi Center
Single Center 916 (70.3%)
Multi Center 387 (29.7%)
Domestic & International
Domestic 771 (59.2%)
International 532 (40.8%)
Surgical Specialty
Bariatric 33 (2.5%)
Breast 56 (4.3%)
Cardiac 17 (1.3%)
Colorectal 137 (10.5%)
Endocrine 126 (9.7%)
General Surgery 205 (15.7%)
Pediatric 34 (2.6%)
Surgical Education/Training 98 (7.5%)
Surgical Oncology 250 (19.2%)
Surgery – Unspecified 72 (5.5%)
Thoracic 39 (3.0%)
Transplant 49 (3.8%)
Trauma/Critical Care 118 (9.1%)
Vascular 42 (3.2%)
Other** 27 (2.1%)
*JAMA = Journal of the American Medical Association.
**Other includes biotech/biodesign (n=4), burn (n=2), neurosurgery (n=6), orthopedic surgery (n=2), healthcare disparities/EMR/epidemiology 
studies (n=8), otolaryngology/HNS (n=2), plastic surgery (n=1), urology (n=2).
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